---
id: 233
title: Malaria
category: clinical_syndromes
subcategory: parasitic
tags: [malaria, Plasmodium-falciparum, artemisinin, atovaquone-proguanil, thick-thin-smear]
difficulty: high
---

## Question

How is malaria managed? Use **"Thick/Thin Smear → Severe: Artesunate IV, Uncomplicated: Artemether-Lumefantrine PO"** framework.

## Answer

### **Epidemiology:**

***Plasmodium* Species:**
- ***P. falciparum*** - most severe, highest mortality
- ***P. vivax, P. ovale*** - cause relapsing disease (hypnozoites in liver)
- ***P. malariae*** - chronic, low-level parasitemia
- ***P. knowlesi*** - zoonotic (Southeast Asia), can be severe

**Geography:**
- **Sub-Saharan Africa** (>90% of deaths, mostly *P. falciparum*)
- **Southeast Asia, South America, Oceania**

### **Clinical Presentation:**

**Classic:**
- **Fever** (cyclical, every 48-72h depending on species)
- **Chills, rigors, sweats**
- **Headache, myalgias**
- **Nausea, vomiting, diarrhea**

**Severe Malaria (***P. falciparum***):**
- **Altered mental status, seizures** (cerebral malaria)
- **Severe anemia** (Hb <7 g/dL)
- **Acute respiratory distress syndrome (ARDS)**
- **Acute kidney injury**
- **Hypoglycemia**
- **Metabolic acidosis** (lactate >5 mmol/L)
- **Shock, circulatory collapse**
- **Parasitemia >5%** (or >2% if non-immune)

### **Diagnosis:**

**Thick and Thin Blood Smears (Gold Standard):**
- **Thick smear:** Screening (higher sensitivity, detects low parasitemia)
- **Thin smear:** Species identification, quantifies parasitemia
- **Repeat q12-24h × 3** if negative but high suspicion

**Rapid Diagnostic Tests (RDTs):**
- **Detects parasite antigens** (HRP-2, pLDH)
- **Result in 15-20 minutes**
- **Sensitivity 95%** for *P. falciparum* (lower for other species)
- **Does NOT quantify parasitemia**

**PCR:**
- **Most sensitive** (detects very low parasitemia)
- **Not widely available** for acute diagnosis

### **Treatment:**

**Severe Malaria (ANY Species):**

**First-Line:**
- **Artesunate 2.4 mg/kg IV bolus** (over 1-2 min)
  - **Repeat at 12h and 24h**, then **daily × 7 days** OR until can take PO
  - **Then switch to oral ACT** (artemether-lumefantrine × 3 days)

**If Artesunate Unavailable:**
- **Quinidine gluconate 6.25 mg/kg IV loading** (over 1-2h) → **0.0125 mg/kg/min continuous infusion**
  - **+ Doxycycline 100mg IV q12h** OR **clindamycin 10 mg/kg IV q8h**
  - **Cardiac monitoring** (QTc prolongation)

**Supportive Care:**
- **ICU monitoring**
- **IV fluids** (avoid overload, risk of ARDS)
- **Blood transfusion** (if Hb <7 g/dL)
- **Treat hypoglycemia, seizures, AKI**

**Uncomplicated Malaria (Non-Severe):**

**First-Line (Artemisinin-Based Combination Therapy, ACT):**
- **Artemether-lumefantrine (Coartem) PO:**
  - **Day 1:** 4 tablets at 0h and 8h
  - **Days 2-3:** 4 tablets BID
  - **Take with food** (↑absorption)

**Alternative ACTs:**
- **Artesunate-mefloquine**
- **Dihydroartemisinin-piperaquine**

**Alternative (If ACT Unavailable):**
- **Atovaquone-proguanil (Malarone) 4 tablets PO daily × 3 days**
- **Quinine sulfate 650mg PO TID × 3-7 days + doxycycline 100mg BID × 7 days** OR **clindamycin**

***P. vivax* / *P. ovale* (Add Primaquine for Hypnozoites):**
- **ACT × 3 days** (treat blood stage)
- **+ Primaquine 30mg PO daily × 14 days** (eradicate liver hypnozoites, prevent relapse)
  - **Check G6PD** before giving primaquine (causes hemolysis in G6PD deficiency)
  - **Alternative:** Tafenoquine 300mg PO × 1 (single dose, but also requires G6PD testing)

**Chloroquine-Sensitive ***P. vivax***/***P. ovale*** (Rare):**
- **Chloroquine 600mg base (1000mg salt) PO, then 300mg base at 6h, 24h, 48h**
- **+ Primaquine** (as above)

### **Monitoring:**

**Parasitemia:**
- **Daily thick/thin smears** until negative × 2 consecutive days
- **Should decrease by 75% at 48h, clear by day 7**

**Hemolysis:**
- **Post-artesunate delayed hemolysis** (7-21 days after treatment)
- **Monitor Hb weekly × 4 weeks** (especially if parasitemia >10%, severe malaria)

### **Chemoprophylaxis (Prevention):**

**High-Risk Areas (***P. falciparum***):**
- **Atovaquone-proguanil (Malarone) 1 tablet PO daily** (1d before → 7d after travel)
- **Doxycycline 100mg PO daily** (1d before → 28d after)
- **Mefloquine 250mg PO weekly** (1-2 weeks before → 4 weeks after)

**Low-Risk (***P. vivax*** Predominant):**
- **Chloroquine 500mg PO weekly** (1 week before → 4 weeks after)

### **Complications:**

**Cerebral Malaria:**
- **Altered mental status, seizures, coma**
- **High mortality** (15-20% despite treatment)
- **Survivors:** 10% have neurologic sequelae

**Blackwater Fever:**
- **Massive intravascular hemolysis** → hemoglobinuria ("black urine")
- **Associated with G6PD deficiency, prior quinine use**

**Splenic Rupture:**
- **Rare, but life-threatening**
- **Sudden abdominal pain, hypotension**

### **Prognosis:**

**Mortality:**
- **Uncomplicated:** <0.1%
- **Severe malaria:** 10-30% (despite treatment)

**Predictors of Poor Outcome:**
- **Cerebral malaria, ARDS, AKI**
- **High parasitemia (>10%)**
- **Hypoglycemia, metabolic acidosis**

## Key Points

### **Severe Malaria = Artesunate IV:**
- **2.4 mg/kg IV at 0h, 12h, 24h**, then daily until can take PO
- **Then switch to oral ACT** (artemether-lumefantrine × 3 days)

### **Uncomplicated = Artemether-Lumefantrine (Coartem):**
- **4 tablets at 0h, 8h (day 1), then BID × 2 more days**
- **Take with food**

### ***P. vivax/ovale* = Add Primaquine:**
- **30mg PO daily × 14 days** (eradicate hypnozoites, prevent relapse)
- **Check G6PD first** (causes hemolysis in deficiency)

### **Thick/Thin Smear = Gold Standard:**
- **Thick:** Screening (high sensitivity)
- **Thin:** Species ID, quantify parasitemia

### **Post-Artesunate Hemolysis:**
- **Monitor Hb weekly × 4 weeks** (delayed hemolysis 7-21 days after treatment)

### **Clinical Pearls:**
- **Severe:** Artesunate 2.4 mg/kg IV (0h, 12h, 24h) → daily, then oral ACT
- **Uncomplicated:** Artemether-lumefantrine (Coartem) × 3 days
- ***P. vivax/ovale*:** Add primaquine 30mg × 14 days (check G6PD first)
- **Thick/thin smear:** Gold standard (repeat q12-24h × 3 if negative)
- **Post-artesunate hemolysis:** Monitor Hb weekly × 4 weeks
- **Prophylaxis:** Atovaquone-proguanil (Malarone) daily OR doxycycline 100mg daily

## Sources

- [CDC: Treatment of Malaria Guidelines 2024]
- [WHO: Guidelines for Malaria 2024]

## Media

N/A
